A novel diagnostic model for HIV-HTN comorbidity: genomic discovery, clinical validation, and mechanistic elucidation

HIV合并高血压的新型诊断模型:基因组发现、临床验证和机制阐明

阅读:1

Abstract

BACKGROUND: Hypertension (HTN) is a frequent comorbidity in people living with Human Immunodeficiency Virus (HIV), yet the shared molecular determinants remain poorly defined. This study aimed to identify diagnostic biomarkers and regulatory networks underlying HIV-HTN comorbidity. METHODS: Transcriptomic datasets from HIV (GSE140713) and HTN (GSE236442) cohorts were analyzed to screen differentially expressed genes. Functional enrichment, GSEA, and PPI analyses were performed to uncover shared pathways and hub genes. Immune cell infiltration was evaluated using CIBERSORT. Transcriptional and post-transcriptional regulatory networks were constructed through NetworkAnalyst, miRNet, and starBase. Key genes were validated in peripheral blood samples from healthy individuals, HIV patients, and HIV-HTN patients using qRT-PCR. RESULTS: A total of 109 overlapping genes were identified, converging on cytokine-cytokine receptor interaction, IL-17, and NF-κB pathways. Six hub genes (FOS, PTGS2, TRMT2A, E2F1, FASN, STAB1) were shared across both diseases. Immune deconvolution showed prominent involvement of DC, monocytes, macrophages, NK/NKT cells, and T-cell subsets. qRT-PCR confirmed consistent upregulation of TRMT2A, E2F1, FASN, and STAB1, and downregulation of FOS and PTGS2. A putative ceRNA network was constructed, highlighting several candidate regulatory miRNAs and lncRNAs. CONCLUSION: This integrative analysis suggests potential molecular signatures and immune-related regulatory axes that may contribute to HIV-HTN comorbidity, providing hypothesis-generating leads for biomarker discovery and mechanistic follow-up studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。